About 100 reports

  • CARDIOVASCULAR DISORDERS TO DOMINATE THE CONTRAST MEDIA/CONTRAST
  • CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2015-2022 (USD MILLION)

The company offers a wide range of contrast media that have applications in gastrointestinal and cardiology disorders.

  • Respiratory Treatment
  • Ultrasound
  • Bracco Imaging S.p.A.
  • GE Healthcare Limited
  • Guerbet Group
  • SEGMENTATION OF GLOBAL PORTABLE ULTRASOUND EQUIPMENT MARKET BY APPLICATION 2016
  • SEGMENTATION OF GLOBAL PORTABLE ULTRASOUND EQUIPMENT MARKET BY APPLICATION
  • Healthcare
  • Ultrasound
  • World
  • Forecast
  • GE Healthcare Limited

It is involved in discovering, developing, manufacturing, and commercializing prescription medicines for the treatment of oncology, cardiovascular and metabolic, respiratory, infection, gastrointestinal, and neuroscience diseases globally.

  • Respiratory Treatment
  • World
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.

Oral ibuprofen at high doses can induce gastrointestinal bleeding and kidney complications when combined with the antibiotics that cystic fibrosis patients also need.

  • Respiratory Treatment
  • Ultrasound
  • World
  • Market Size
  • AbbVie Inc.
  • ASTRAZENECA: BUSINESS SEGMENTATION BY REVENUE 2013 AND 2014 ($ BILLIONS)
  • ASTRAZENECA

INFECTION, NEUROSCIENCE, AND GASTROINTESTINAL RESPIRATORY, INFLAMMATION, AND AUTOIMMUNITY In FY2014, this segment generated $##. ## billion, which was ##. ##% higher than the segment' s revenue in FY2013.

  • Allergy Drug
  • Respiratory Treatment
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Trial Results
  • Drug Details

Eosinophils are pro-inflammatory cells that make a major contribution to allergic diseases affecting the upper and lower airways, skin and gastrointestinal tract.

  • Respiratory Treatment
  • World
  • GlaxoSmithKline plc
  • Regeneron Pharmaceuticals, Inc.
  • Sanofi S.A.

THE COMPANY' S OVERALL PHARMACEUTICAL PORTFOLIO COVERS A VARIETY OF THERAPEUTIC AREAS, INCLUDING CV AND METABOLIC DISORDERS, NEUROSCIENCE, GASTROINTESTINAL DISORDERS, ONCOLOGY, RESPIRATORY, AND INFECTIOUS DISEASES.

  • Respiratory Treatment
  • Demand
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Sunovion Pharmaceuticals Inc.
  • ASTRAZENECA: BUSINESS SEGMENTATION BY REVENUE 2013 AND 2014

gastrointestinal diseases.

  • Respiratory Treatment
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG

Abdominal or gastrointestinal disorders affect many people.

  • CT Scan
  • Hospital
  • Ultrasound
  • GE Healthcare Limited
  • Toshiba Corporation

It is performed under general or upper and colorectal gastrointestinal surgeons who have a specialist interest in gastrointestinal surgery for treating barrett' s esophagus, Gastroesophageal Reflux Disease (GERD), gallbladder, hernias and colon/ rectum diseases.

  • Ultrasound
  • World
  • ATON GmbH
  • Medtronic, Inc.
  • Siemens AG
  • RESPIRATORY DISORDERS THERAPEUTICS MARKET, GLOBAL, MERCK & CO. ANNUAL REVENUE
  • 2.7.4 CYSTIC FIBROSIS

AS CF IS A MULTI-SYSTEM DISEASE, EVEN IF THE LUNG TRANSPLANT IS SUCCESSFUL, PANCREATIC, GASTROINTESTINAL AND REPRODUCTIVE PROBLEMS WILL REMAIN.

  • Respiratory Treatment
  • World
  • Market Size
  • Astellas Pharma Inc.
  • AstraZeneca PLC

gastrointestinal diseases.

  • Respiratory Treatment
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Key vendor analysis

gastrointestinal diseases.

  • Respiratory Treatment
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co., Inc.
  • Key vendor analysis

gastrointestinal diseases.

  • Respiratory Treatment
  • World
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Novartis AG
  • 3D/4D ultrasound equipment market in EMEA
  • Others

In EMEA, the increasing prevalence of gastrointestinal diseases, kidney stone, and the growing number of obese patients are expected to drive the demand for advanced ##D/ ##D ultrasound equipment during the forecast period.

  • Ultrasound
  • GE Healthcare Limited
  • Koninklijke Philips N.V.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Toshiba Corporation

NUCLEAR IMAGING SYSTEMS Nuclear imaging uses small amounts of radioactive materials, which are called radiotracers, that are typically injected into the bloodstream, inhaled, or swallowed to diagnose and determine the severity of diseases such as cancers, heart disease, gastrointestinal dis

  • Diagnostic Imaging
  • Ultrasound
  • X Ray System
  • GE Healthcare Limited
  • Hitachi, Ltd.

NUCLEAR MEDICINE IS A SPECIALIZED BRANCH OF MEDICAL IMAGING THAT USES MINUTE AMOUNTS OF RADIOACTIVE MATERIALS, RADIOPHARMACEUTICALS, OR RADIOTRACERS TO DIAGNOSE/ DETERMINE DISEASE SEVERITY AND TREAT A WIDE SPECTRUM OF DISEASES, INCLUDING CANCERS, HEART DISEASES, GASTROINTESTINAL AND END

  • Ultrasound
  • World
  • Market Size
  • FUJIFILM Holdings Corporation
  • Koninklijke Philips N.V.
  • Medical imaging in neurology

Due to this reason, physicians prefer color doppler imaging modalities for gastrointestinal organ scanning.

  • Ultrasound
  • FUJIFILM Holdings Corporation
  • GE Healthcare Limited
  • Hitachi, Ltd.
  • Toshiba Corporation
  • CARDIOLOGY
  • OTHERS

So, physicians prefer color Doppler ultrasound imaging for gastrointestinal scanning.

  • Ultrasound
  • World
  • Forecast
  • GE Healthcare Limited
  • Toshiba Corporation
  • 18.5 PRODUCT NEWS

BARIUM CONTRAST AGENTS ARE USED IN PROCEDURES RELATED TO THE GASTROINTESTINAL TRACT.

  • Respiratory Treatment
  • Ultrasound
  • Asia
  • Japan
  • Market Size

Therapy drugs are mainly used in respiratory diseases, gastrointestinal diseases.

  • Respiratory Treatment
  • China
  • Demand
  • Roche Group
  • Xincat Pharmaceutical Co., Ltd.

Chapter Six: Gastrointestinal Drugs Figure ##-## U. S.

  • Respiratory Treatment
  • United States
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

BARIUM CONTRAST AGENTS ARE USED IN PROCEDURES RELATED TO THE GASTROINTESTINAL TRACT.

  • Ultrasound
  • Brazil
  • South America
  • Market Size
  • GE Healthcare Limited
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

BARIUM CONTRAST AGENTS ARE USED IN PROCEDURES RELATED TO THE GASTROINTESTINAL TRACT.

  • Respiratory Treatment
  • Ultrasound
  • Europe
  • Italy
  • Market Size
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

BARIUM CONTRAST AGENTS ARE USED IN PROCEDURES RELATED TO THE GASTROINTESTINAL TRACT.

  • Ultrasound
  • Asia
  • South Korea
  • Market Size
  • GE Healthcare Limited
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

BARIUM CONTRAST AGENTS ARE USED IN PROCEDURES RELATED TO THE GASTROINTESTINAL TRACT.

  • Ultrasound
  • Mexico
  • North America
  • Market Size
  • GE Healthcare Limited
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

BARIUM CONTRAST AGENTS ARE USED IN PROCEDURES RELATED TO THE GASTROINTESTINAL TRACT.

  • Ultrasound
  • Europe
  • Russian Federation
  • Market Size
  • GE Healthcare Limited
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

BARIUM CONTRAST AGENTS ARE USED IN PROCEDURES RELATED TO THE GASTROINTESTINAL TRACT.

  • Ultrasound
  • Europe
  • Spain
  • Market Size
  • Bruker Corporation

The products include Copanlisib, for the treatment of various types of cancer; Stivarga, an oral multikinase inhibitor that is used for the treatment of gastrointestinal stromal tumors; Bay ##-##, used to treat hemophilia; Xofigo, used to treat castrationresistant prostate cancer; and Nex

  • Respiratory Treatment
  • Actelion Ltd
  • Bayer AG
  • GlaxoSmithKline plc
  • United Therapeutics Corporation
  • MARKET SHARE ANALYSIS 2015

gastrointestinal diseases.

  • Respiratory Treatment
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG